Patent · US Active

Antibodies that bind tumor tissue for diagnosis and therapy

US11472885B2 · kind B2 · utility

1Cited by
0References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 14, 2020
Grant dateOct 18, 2022
Priority date
Expiry dateJul 8, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/732
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.